| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | maintenance of postsynaptic density structure | 4.65e-05 | 9 | 24 | 2 | GO:0099562 | |
| GeneOntologyBiologicalProcess | rRNA processing | 1.34e-04 | 230 | 24 | 4 | GO:0006364 | |
| GeneOntologyBiologicalProcess | maintenance of postsynaptic specialization structure | 1.75e-04 | 17 | 24 | 2 | GO:0098880 | |
| GeneOntologyCellularComponent | sno(s)RNA-containing ribonucleoprotein complex | 6.45e-06 | 32 | 24 | 3 | GO:0005732 | |
| GeneOntologyCellularComponent | box C/D RNP complex | 2.64e-05 | 7 | 24 | 2 | GO:0170049 | |
| GeneOntologyCellularComponent | box C/D methylation guide snoRNP complex | 2.64e-05 | 7 | 24 | 2 | GO:0031428 | |
| Domain | BAH | 9.39e-05 | 11 | 25 | 2 | SM00439 | |
| Domain | BAH | 9.39e-05 | 11 | 25 | 2 | PF01426 | |
| Domain | BAH_dom | 9.39e-05 | 11 | 25 | 2 | IPR001025 | |
| Domain | BAH | 9.39e-05 | 11 | 25 | 2 | PS51038 | |
| Domain | BTB-kelch_protein | 1.50e-03 | 43 | 25 | 2 | IPR017096 | |
| Domain | Kelch-typ_b-propeller | 2.45e-03 | 55 | 25 | 2 | IPR015915 | |
| Domain | Kelch | 2.72e-03 | 58 | 25 | 2 | SM00612 | |
| Domain | Gal_Oxase/kelch_b-propeller | 2.81e-03 | 59 | 25 | 2 | IPR011043 | |
| Domain | BACK | 2.90e-03 | 60 | 25 | 2 | SM00875 | |
| Domain | BACK | 3.00e-03 | 61 | 25 | 2 | PF07707 | |
| Domain | BACK | 3.00e-03 | 61 | 25 | 2 | IPR011705 | |
| Domain | Kelch_1 | 3.93e-03 | 70 | 25 | 2 | PF01344 | |
| Domain | Kelch_1 | 3.93e-03 | 70 | 25 | 2 | IPR006652 | |
| Domain | BTB | 1.32e-02 | 131 | 25 | 2 | PF00651 | |
| Domain | PDZ | 1.52e-02 | 141 | 25 | 2 | PF00595 | |
| Domain | PDZ | 1.66e-02 | 148 | 25 | 2 | SM00228 | |
| Domain | - | 1.70e-02 | 150 | 25 | 2 | 2.30.42.10 | |
| Domain | PDZ | 1.72e-02 | 151 | 25 | 2 | PS50106 | |
| Domain | PDZ | 1.75e-02 | 152 | 25 | 2 | IPR001478 | |
| Domain | BTB | 1.92e-02 | 160 | 25 | 2 | PS50097 | |
| Pubmed | 6.49e-06 | 1497 | 25 | 8 | 31527615 | ||
| Pubmed | Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. | 9.98e-06 | 190 | 25 | 4 | 15161933 | |
| Pubmed | 2.14e-05 | 483 | 25 | 5 | 36912080 | ||
| Pubmed | Cell-fate determination by ubiquitin-dependent regulation of translation. | 4.49e-05 | 14 | 25 | 2 | 26399832 | |
| Pubmed | 5.53e-05 | 103 | 25 | 3 | 32744500 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 9.53e-05 | 1082 | 25 | 6 | 38697112 | |
| Pubmed | 1.13e-04 | 1116 | 25 | 6 | 31753913 | ||
| Pubmed | Regulation of planar cell polarity by Smurf ubiquitin ligases. | 1.47e-04 | 25 | 25 | 2 | 19379695 | |
| Pubmed | 1.52e-04 | 731 | 25 | 5 | 29298432 | ||
| Pubmed | SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice. | 1.69e-04 | 150 | 25 | 3 | 30154076 | |
| Pubmed | Dlg5 maintains apical aPKC and regulates progenitor differentiation during lung morphogenesis. | 1.72e-04 | 27 | 25 | 2 | 23466739 | |
| Pubmed | 1.79e-04 | 153 | 25 | 3 | 10718198 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 1.81e-04 | 759 | 25 | 5 | 35915203 | |
| Pubmed | 1.89e-04 | 156 | 25 | 3 | 29961565 | ||
| Pubmed | 2.11e-04 | 417 | 25 | 4 | 36537216 | ||
| Pubmed | 2.15e-04 | 419 | 25 | 4 | 15635413 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 2.16e-04 | 1257 | 25 | 6 | 36526897 | |
| Pubmed | 2.31e-04 | 167 | 25 | 3 | 35833506 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 3.23e-04 | 861 | 25 | 5 | 36931259 | |
| Pubmed | 3.45e-04 | 1371 | 25 | 6 | 36244648 | ||
| Pubmed | 4.00e-04 | 41 | 25 | 2 | 23676014 | ||
| Pubmed | 4.61e-04 | 44 | 25 | 2 | 27505670 | ||
| Pubmed | 5.26e-04 | 47 | 25 | 2 | 15009096 | ||
| Pubmed | 5.31e-04 | 1487 | 25 | 6 | 33957083 | ||
| Pubmed | Spatiotemporal gene expression patterns reveal molecular relatedness between retinal laminae. | 5.71e-04 | 49 | 25 | 2 | 31609468 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 6.65e-04 | 565 | 25 | 4 | 25468996 | |
| Pubmed | 6.83e-04 | 242 | 25 | 3 | 34011540 | ||
| Interaction | BRPF3 interactions | 1.66e-06 | 166 | 25 | 5 | int:BRPF3 | |
| Interaction | FGFBP1 interactions | 1.40e-05 | 257 | 25 | 5 | int:FGFBP1 | |
| Interaction | RPL18A interactions | 1.43e-05 | 447 | 25 | 6 | int:RPL18A | |
| Interaction | RPL10 interactions | 1.68e-05 | 702 | 25 | 7 | int:RPL10 | |
| Interaction | POP1 interactions | 2.01e-05 | 277 | 25 | 5 | int:POP1 | |
| Interaction | ZNF81 interactions | 2.21e-05 | 6 | 25 | 2 | int:ZNF81 | |
| Interaction | RHOBTB2 interactions | 4.79e-05 | 165 | 25 | 4 | int:RHOBTB2 | |
| Interaction | RMRP interactions | 5.29e-05 | 9 | 25 | 2 | int:RMRP | |
| Interaction | ARHGAP42 interactions | 5.51e-05 | 60 | 25 | 3 | int:ARHGAP42 | |
| Interaction | USP36 interactions | 7.35e-05 | 599 | 25 | 6 | int:USP36 | |
| Interaction | WDR36 interactions | 1.18e-04 | 208 | 25 | 4 | int:WDR36 | |
| Interaction | PARD6A interactions | 1.21e-04 | 78 | 25 | 3 | int:PARD6A | |
| Interaction | PDCD11 interactions | 1.22e-04 | 405 | 25 | 5 | int:PDCD11 | |
| Interaction | NOP2 interactions | 1.38e-04 | 416 | 25 | 5 | int:NOP2 | |
| Interaction | UTRN interactions | 1.38e-04 | 217 | 25 | 4 | int:UTRN | |
| Interaction | ZNF106 interactions | 1.50e-04 | 84 | 25 | 3 | int:ZNF106 | |
| Interaction | CEP104 interactions | 1.78e-04 | 89 | 25 | 3 | int:CEP104 | |
| Interaction | GOLIM4 interactions | 1.97e-04 | 92 | 25 | 3 | int:GOLIM4 | |
| GeneFamily | Kelch like|BTB domain containing | 5.43e-04 | 42 | 15 | 2 | 617 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 5.37e-03 | 134 | 15 | 2 | 861 | |
| GeneFamily | PDZ domain containing | 6.86e-03 | 152 | 15 | 2 | 1220 | |
| Coexpression | SUNG_METASTASIS_STROMA_DN | 1.84e-05 | 54 | 25 | 3 | M2904 | |
| Coexpression | GSE11057_CD4_CENT_MEM_VS_PBMC_UP | 3.53e-05 | 198 | 25 | 4 | M3116 | |
| Coexpression | FUNG_IL2_SIGNALING_1 | 3.91e-05 | 10 | 25 | 2 | M14139 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-06 | 166 | 25 | 4 | b21e45bd43f26149b9cd6e45c19241c82d54fb2f | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-06 | 166 | 25 | 4 | 13027ae342994db4540e64eb910df1f42b160931 | |
| ToppCell | AT1-AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.17e-04 | 171 | 25 | 3 | 0b9912f07393aca889db72b40da08e0bc9bc1e8c | |
| ToppCell | droplet-Marrow-nan-21m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 188 | 25 | 3 | 7c67330c36696a7772364af67c6df4e6406fa742 | |
| ToppCell | droplet-Marrow-nan-21m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 188 | 25 | 3 | f94dc08948a823f47882aa0714b9a60de4ff85d5 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 191 | 25 | 3 | 45023854f285ac465f23ea1b33c970e14992e709 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 191 | 25 | 3 | 6890a8e4b4530987a5b044614fcd7e00716a4d66 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 192 | 25 | 3 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.67e-04 | 193 | 25 | 3 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | CD8+_Memory_T_cell-CV-0|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.67e-04 | 193 | 25 | 3 | 995781d87a919c0380750878bafe584342bb83ad | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.69e-04 | 194 | 25 | 3 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-04 | 195 | 25 | 3 | f4f53fcfcce9d4337e09f1f8582a9c813ed40c35 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.72e-04 | 195 | 25 | 3 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.77e-04 | 197 | 25 | 3 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.77e-04 | 197 | 25 | 3 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | Control-PLT_4|Control / Disease Group and Platelet Clusters | 1.80e-04 | 198 | 25 | 3 | 387fd3037fd52e4d4c42de0588767e58af228b59 | |
| ToppCell | CV-Severe-2|Severe / Virus stimulation, Condition and Cluster | 1.80e-04 | 198 | 25 | 3 | 254659bb53dc2511c714295c2df1ab1fddb2f867 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-04 | 198 | 25 | 3 | d5e125f0c4f41b47d567568d0838adcca7655f6d | |
| ToppCell | CV-Moderate-2|Moderate / Virus stimulation, Condition and Cluster | 1.82e-04 | 199 | 25 | 3 | 70d6f2a328eec4cb2cecb7cd85859fba9e15c9c8 | |
| ToppCell | CD8+_Memory_T_cell-CV-2|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.82e-04 | 199 | 25 | 3 | 1e33d8e2e0d6a54ef6e2e13f986e19fd209275a8 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.82e-04 | 199 | 25 | 3 | c88a28a73f54dc571f2ff1e4b55073f83cbead2c | |
| ToppCell | CV-Moderate-2|CV / Virus stimulation, Condition and Cluster | 1.82e-04 | 199 | 25 | 3 | 2d98424a5247e87f98095c11fb945289092a9d75 | |
| ToppCell | critical-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.85e-04 | 200 | 25 | 3 | f39db4250ce220a3eb58edee3f7fc3671701d46f | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.83e-06 | 191 | 25 | 5 | 5204_DN | |
| Drug | Methoxamine hydrochloride [61-16-5]; Down 200; 16.2uM; PC3; HT_HG-U133A | 5.85e-05 | 196 | 25 | 4 | 6627_DN | |
| Drug | Iodixanol [92339-11-2]; Down 200; 2.6uM; MCF7; HT_HG-U133A | 5.85e-05 | 196 | 25 | 4 | 3362_DN | |
| Drug | Ioversol [87771-40-2]; Down 200; 5uM; PC3; HT_HG-U133A | 6.08e-05 | 198 | 25 | 4 | 6726_DN | |
| Drug | Moricizine hydrochloride [31883-05-3]; Up 200; 8.6uM; PC3; HT_HG-U133A | 6.20e-05 | 199 | 25 | 4 | 7297_UP | |
| Drug | Norfloxacin [70458-96-7]; Up 200; 12.6uM; HL60; HG-U133A | 6.20e-05 | 199 | 25 | 4 | 1406_UP | |
| Drug | Pyrazinamide [ 98-96-4]; Down 200; 32.4uM; PC3; HT_HG-U133A | 6.20e-05 | 199 | 25 | 4 | 6617_DN | |
| Drug | Hydroquinine hydrobromide hydrate [304695-81-6]; Down 200; 9.4uM; PC3; HT_HG-U133A | 6.20e-05 | 199 | 25 | 4 | 5789_DN | |
| Disease | retinal detachment, retinal break | 4.03e-04 | 35 | 25 | 2 | EFO_0005773, EFO_0010698 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 7.91e-04 | 49 | 25 | 2 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Profound Mental Retardation | 6.16e-03 | 139 | 25 | 2 | C0020796 | |
| Disease | Mental deficiency | 6.16e-03 | 139 | 25 | 2 | C0917816 | |
| Disease | Mental Retardation, Psychosocial | 6.16e-03 | 139 | 25 | 2 | C0025363 | |
| Disease | Intellectual Disability | 6.20e-03 | 447 | 25 | 3 | C3714756 | |
| Disease | serum gamma-glutamyl transferase measurement | 6.89e-03 | 914 | 25 | 4 | EFO_0004532 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 7.32e-03 | 152 | 25 | 2 | DOID:0060041 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LGKGRKLSKVKHKAG | 1831 | Q9P281 | |
| HKKSGRSKEKRKSKH | 2306 | Q9NR48 | |
| KKTLGRKRGHKGSFK | 196 | Q5VV41 | |
| KGKISHDKRKKSRSK | 211 | Q71F23 | |
| HKFRRKSKVKEAKSG | 791 | Q9UPM8 | |
| KGKSFRHEKTKKKRG | 666 | Q14978 | |
| HKLKEKAKKRKGRGF | 26 | Q9Y5S9 | |
| GHRSGSKKKRKFSKE | 551 | O00567 | |
| DKKKKGKGKRHQDRG | 601 | Q8N4N3 | |
| KKVRFVHSKEKLRKG | 1176 | Q86XX4 | |
| RSFKHKGKKFRPTAK | 531 | Q9NY93 | |
| RKHKHKRSGSKDGKD | 1691 | Q8TDM6 | |
| HEGRITTLRKKKKGK | 261 | Q2TBA0 | |
| GQRTTKSKKKKGHKG | 811 | Q96MT3 | |
| KRGKKKVKLHSYTGK | 421 | Q68D51 | |
| KKRTFTKGVKVKHGA | 881 | Q12967 | |
| DGKKKTTFFKRGKKL | 421 | O75881 | |
| KKRASFKRKSSKKGP | 261 | Q13574 | |
| FGKHRKDDKIEKTGK | 1026 | Q8TEW0 | |
| FTRHKRKEKKKKAKG | 61 | O95707 | |
| HFFGDKALKKRSGKK | 691 | Q96AQ6 | |
| HRRKSKHKSAKKKTG | 1046 | O60673 | |
| KKKKKTRGDHFKLRF | 66 | O43257 | |
| GRTKTTKGFKLGKHK | 1581 | Q69YN4 | |
| SHKKRNTGKKVFKCK | 171 | Q8NEM1 |